SCIENTISTS have marked two years since the launch of the world’s first commercially available PCR test for Covid-19.
Roche Diagnostics UK, based in Burgess Hill, was among the first to analyze the genetic sequence of the virus with its test made available on March 13, 2020 and rolled out to the frontline NHS in just three weeks at an unprecedented rate.
The company has since developed more than 20 diagnostic tests for Covid-19 to support the pandemic response.
Over the past two years, almost ten million tests have been supplied by the company, with distribution coordinated from the company’s headquarters in Sussex.
Geoff Twist, Managing Director of Roche Diagnostics UK and Ireland, said: “As a country we have sacrificed so much over the past two years, but we have also seen the best, thanks to the dedication of our NHS workers and the resilience of our communities. , to the remarkable innovation of our scientists.
“I am so proud of the role Roche Diagnostics has played in the response to the pandemic and of our teams who have worked day and night to support the NHS and provide the country with life-saving Covid-19 tests in record time.
“But our determination and commitment don’t stop there. The NHS has another huge mountain to climb in the months and years ahead and the untapped potential of diagnostics can play an important role in helping to tackle the unprecedented waiting lists created by the pandemic and future challenges.
Founded in 1896, the company is one of the largest biotechnology companies in the world and claims to be a world leader in in vitro diagnostics.
More about this article: Read More
Source: www.theargus.co.uk
This notice was published: 2022-03-15 14:34:20
